The France Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The France Journal.

Press releases published on July 1, 2026

Jul. 1, 2026

Abivax annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris

Indeterminate GlobeNewswire

Jul. 1, 2026

Abivax annonce la fixation du prix de l’Offre au public largement sursouscrite de 800 M$ (702 M€) d’American Depositary Shares

Indeterminate GlobeNewswire

Jul. 1, 2026

Abivax Announces Pricing of Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares

Indeterminate GlobeNewswire

Jul. 1, 2026

newcleo to acquire nuclear scales manufacturer Bonifait Pesage, strengthening its vertical integration

Indeterminate GlobeNewswire

Jul. 1, 2026

Step Pharma announces the appointment of Neil Gallagher as Non-Executive Director

Indeterminate GlobeNewswire

Jul. 1, 2026

Virtune erweitert den Virtune Stablecoin Index ETP um vier neue Krypto-Assets: BNB (BNB), Canton (CC), Ethena (ENA) und TRON (TRX)

Indeterminate GlobeNewswire

Jul. 1, 2026

Virtune adds four new crypto assets to the Virtune Stablecoin Index ETP: Ethena (ENA), Canton (CC), TRON (TRX), and BNB (BNB)

Indeterminate GlobeNewswire

Jul. 1, 2026

Virtune lisää neljä uutta kryptovaraa Virtune Stablecoin Index ETP:hen: Ethena (ENA), Canton (CC), TRON (TRX) ja BNB (BNB)

Indeterminate GlobeNewswire

Jul. 1, 2026

Virtune inkluderar fyra nya kryptotillgångar i Virtune Stablecoin Index ETP: Ethena (ENA), Canton (CC), TRON (TRX) och BNB (BNB)

Indeterminate GlobeNewswire

Jul. 1, 2026

Press Release: Availability of the aide-mémoire for Q2 2026 results

Indeterminate GlobeNewswire

Jul. 1, 2026

Communiqué de presse : Mise en ligne du document «Q2 2026 aide-mémoire »

Indeterminate GlobeNewswire

Jul. 1, 2026

Nicox’s NCX 470 New Drug Application Submitted in the United States by Kowa, with Associated €3 million Milestone Payment

Indeterminate GlobeNewswire

Jul. 1, 2026

Nicox : Demande d’autorisation de mise sur le marché de NCX 470 soumise aux Etats-Unis par Kowa, avec un paiement d’étape de 3 millions d’euros associé

Indeterminate GlobeNewswire

Jul. 1, 2026

Abivax announces temporary trading halt of its ordinary shares on Euronext Paris

Indeterminate GlobeNewswire

Jul. 1, 2026

Abivax annonce la suspension temporaire du cours de ses actions ordinaires sur Euronext Paris

Indeterminate GlobeNewswire

Jul. 1, 2026

Ipsen to acquire Memo Therapeutics AG, adding first-in-class BK polyomavirus antibody, expanding rare disease portfolio

Indeterminate GlobeNewswire

Jul. 1, 2026

Ipsen va acquérir Memo Therapeutics AG, élargissant son portefeuille de maladies rares grâce à l’ajout d’un anticorps premier de sa classe ciblant le polyomavirus BK  

Indeterminate GlobeNewswire